The prognostic value of mesenchymal CTCs in pancreatic cancer is not clear; however, in a study by Poruk et al., the detection of vimentin on CK-positive CTCs was associated with disease recurrence [18]. This evidence concerns the gene VIM and familial pancreatic carcinoma.